Harvard Bioscience, Inc. (HBIO)

0.7341 +0.01 (+1.85%) USD  |  NASDAQ  |  Dec 24, 12:59
0.73 0.00 (0.00%) After-Hours: 13:59
More

Harvard Bioscience CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for HBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Bruker Corp. Upgrade
Azenta, Inc. Upgrade
Precipio, Inc. Upgrade
Bionano Genomics, Inc. Upgrade
Kestra Medical Technologies Ltd. Upgrade